Immune System News and Research

RSS

Crohn's disease appears to have two distinct genetic subtypes, study finds

Crohn's disease, a common inflammatory disorder of the intestinal tract, can have devastating consequences for a patient's quality of life and is notoriously hard to treat successfully, in part because its course and severity vary so much from one case to the next.

14 Oct 2016

Portsmouth scientist wins major award to develop treatments for MS patients

A University of Portsmouth scientist has won almost £180,000 to fund research that could help develop treatments for multiple sclerosis (MS) patients.

14 Oct 2016

FAAM 2016: Experts discuss advancements in diagnosis, management of food allergies and anaphylaxis

The European Academy of Allergy and Clinical Immunology has announced today the inauguration of its 4th Food Allergy and Anaphylaxis Meeting (FAAM), hosting over 1,200 international researchers, clinicians and allied health professionals in Rome from 13–15 October 2016.

14 Oct 2016

Mount Sinai awarded $10 million grant to explore cellular, molecular mechanisms of GVHD

Researchers from the Icahn School of Medicine at Mount Sinai have been awarded a $10 million from the National Cancer Institute to explore the cellular and molecular mechanisms of acute graft-versus-host disease (GVHD), a common side effect that occurs after allogeneic bone marrow transplantation (BMT), and to develop novel therapeutic strategies for BMT patients with cancer that begin in the cells of blood-forming tissue or hematologic malignancies.

13 Oct 2016

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Scientists at Houston Methodist received support from the U.S. Department of Defense to reprogram cancer patients' immune cells to attack triple negative breast cancer, the most lethal form of breast cancer.

13 Oct 2016

Clinical study to determine safety, efficacy of allogeneic CDCs for patients with myocardial infarction

A multi-center team of researchers are planning a clinical trial using cardiosphere-derived cells (CDCs) (a heterogeneous cluster of proliferating cardiac cells that include mesenchymal stem cells) to regenerate the tissue and improve function of the heart in patients who have suffered heart attacks (myocardial infarction, MI).

13 Oct 2016

New evolutionary analysis provides insights into how Zika virus spreads between populations

In a study published in Pathogens and Global Health, researchers have modelled the evolutionary development and diversity of the Zika virus to better understand how infection spreads between populations and how the virus reacts with the immune system.

13 Oct 2016

High folate intake may increase risk of peripheral neuropathy in older adults with common gene variant

Consuming too much folate (vitamin B9) is associated with increased risk for a nerve-damage disorder in older adults who have a common genetic variant.

12 Oct 2016

Study suggests possibility for small molecule drug/antibody combinatorial therapy to treat neuroblastoma

A study by a multidisciplinary team of researchers from The Saban Research Institute of Children's Hospital Los Angeles sheds further light on the role of the cytokine TGFβ1 in the growth of neuroblastoma, and suggests the possibility for a small molecule drug/antibody combinatorial therapy to treat this cancer.

12 Oct 2016

Research findings raise hope for better treatment of diabetic wounds

Diabetics often have to contend with wounds that heal poorly. Researchers at the Max Planck Institute for Biology of Ageing, the CECAD Excellence Cluster and the Institute of Genetics of the University of Cologne have now gained fresh insights into the underlying cellular mechanisms.

12 Oct 2016

New T cell subset may play vital role in development of type 1 diabetes

A study conducted at the University of Eastern Finland revealed that a recently described T cell subset may have a central role in the development of type 1 diabetes.

12 Oct 2016

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

Results of preclinical studies by investigators at the Medical University of South Carolina reported in the August 2016 issue of Arthritis & Rheumatology demonstrate for the first time that including novel biomarkers in lupus nephritis (LN) prognostic models significantly increases their power to predict therapeutic efficacy.

12 Oct 2016

Immune System News and Research

Crohn's disease appears to have two distinct genetic subtypes, study finds

Portsmouth scientist wins major award to develop treatments for MS patients

FAAM 2016: Experts discuss advancements in diagnosis, management of food allergies and anaphylaxis

Mount Sinai awarded $10 million grant to explore cellular, molecular mechanisms of GVHD

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Clinical study to determine safety, efficacy of allogeneic CDCs for patients with myocardial infarction

New evolutionary analysis provides insights into how Zika virus spreads between populations

High folate intake may increase risk of peripheral neuropathy in older adults with common gene variant

Study suggests possibility for small molecule drug/antibody combinatorial therapy to treat neuroblastoma

Research findings raise hope for better treatment of diabetic wounds

New T cell subset may play vital role in development of type 1 diabetes

Novel biomarkers enhance power to predict therapeutic efficacy in LN prognostic models

New research shows mother's milk helps baby to make copies of maternal immune cells

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

Study explores antimicrobial and antiinflammatory activities of bovine colostrum

Researchers explain why explain why some tumors recur after immunotherapy

Study provides new insights into Zika's rapid infection and risk for transmission

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News